Ana Carolina Aguiar Vasconcelos Carneiro Selected Research

Congenital Toxoplasmosis

11/2021	Long-term impact of congenital toxoplasmosis on phenotypic and functional features of circulating leukocytes from infants one year after treatment onset.
10/2020	Putative biomarkers for early diagnosis and prognosis of congenital ocular toxoplasmosis.
12/2017	Establishing tools for early diagnosis of congenital toxoplasmosis: Flow cytometric IgG avidity assay as a confirmatory test for neonatal screening.
1/2017	Early serum biomarker networks in infants with distinct retinochoroidal lesion status of congenital toxoplasmosis.
1/2016	IgA and IgG1 reactivities assessed by flow cytometry mirror clinical aspects of infants with ocular congenital toxoplasmosis.
1/2016	Cytokine Signatures Associated With Early Onset, Active Lesions and Late Cicatricial Events of Retinochoroidal Commitment in Infants With Congenital Toxoplasmosis.
1/2014	Biomarker analysis revealed distinct profiles of innate and adaptive immunity in infants with ocular lesions of congenital toxoplasmosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ana Carolina Aguiar Vasconcelos Carneiro Research Topics

Disease

7	Congenital Toxoplasmosis 11/2021 - 01/2014
1	Ocular Toxoplasmosis 10/2020
1	Leukocytosis (Pleocytosis) 01/2014

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2014
3	CytokinesIBA 01/2017 - 01/2016
2	Immunoglobulin G (IgG)IBA 12/2017 - 01/2016
1	Interleukin-5 (Interleukin 5)IBA 10/2020
1	Thomsen-Friedenreich antibodiesIBA 12/2017
1	Immunoglobulin M (IgM)IBA 12/2017
1	ChemokinesIBA 01/2017
1	Immunoglobulin A (IgA)IBA 01/2016

Therapy/Procedure

1	Aftercare (After-Treatment) 11/2021